[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Salem Anaesthesia Pain Clinic\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":255},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,12,0,[8,46,67,86,105,123,142,162,181,201,219,236],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100523978","chronic-pelvic-pain-in-females-and-males-100523978",false,"NCT06102733","Chronic Pelvic Pain in Females and Males","Chronic Pelvic Pain Management in Female and Male Adult Patients","Inclusion Criteria:\n\n* Patients with chronic pelvic pain\n* Patients with sacroiliac pain\n* Patients with inguinal pain\n* Patients with coccygeal pain\n* Patients with piriformis pain\n\nExclusion Criteria:\n\n* Patients with spinal pain\n* Patients who had spine surgery",true,"ALL","20 Years","99 Years",{"count":21,"type":22},1000,"ESTIMATED","OBSERVATIONAL","Pelvic pain is under-reported in healthy adults. Many patients with pelvic pain under-estimate the problem. Chronic pelvic pain can be managed properly, if diagnosed promptly.\n\nThis is a quantitative analysis of prospective clinical data. It evaluates the management of pelvic pain in a cohort population, and analyzes the treatment outcome.",[26,27,28,29,30],"Pelvic Pain Syndrome","Sacroiliac Disorder","Piriformis Syndrome","Sacrococcygeal Disorder","Inguinal Hernia",[32],"Pelvic pain","RECRUITING","2025-01-23",{"date":36,"type":37},"2025-01-27","ACTUAL",{"date":39,"type":37},"2018-01-02",{"date":41,"type":22},"2025-12-31",{"name":43,"class":44},"Salem Anaesthesia Pain Clinic","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":53,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":54,"conditions":55,"keywords":60,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":63,"startDateStruct":64,"completionDateStruct":65,"leadSponsor":66,"locationsCount":45},"100524105","characteristics-of-injury-claims-by-chronic-pain-patients-100524105","NCT06104384","Characteristics of Injury Claims by Chronic Pain Patients","Socio-demographics of Injury Insurance Claims by Chronic Pain Patients","Inclusion Criteria:\n\n* adult chronic pain patients\n* patients with injury claim\n\nExclusion Criteria:\n\n* pediatric patients\n* patients without injury claim",{"count":21,"type":22},"Chronic pain is associated with injuries and disabilities. This prospective observational study explores the injury or disability claims made by chronic pain patients. It evaluates the socio-demographics of the patient population. It explores the impact of pain clinic services on the patients' injury rehabilitation, insurance claim outcome, and socioeconomic situation.",[56,57,58,59],"Social Functioning","Chronic Pain","Injuries","Disabilities Multiple",[61,62],"Injury Claim","Disability Claim",{"date":36,"type":37},{"date":39,"type":37},{"date":41,"type":22},{"name":43,"class":44},{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":4,"eligibilityCriteria":73,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":74,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":75,"conditions":76,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":81,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":85,"locationsCount":45},"100521970","pain-clinic-provides-public-health-safety-100521970","NCT06076512","Pain Clinic Provides Public Health Safety","Pain Clinic Provides Public Health and Safety Services","Inclusion Criteria:\n\n* adult chronic pain patients\n* patients with psychosocial problems\n\nExclusion Criteria:\n\n* pediatric patients\n* patients with severe cognitive dysfunction",{"count":21,"type":22},"Chronic pain is associated with psychological disorders; which may affect a patient's socioeconomic, legal, domestic, and employment situations. This prospective observational study evaluates the impact of pain management on patients' health, social, economic, and employment status. It explores the impact of pain clinic services on patients' mental health, family health, public health, road safety, addiction situation, public safety, injury rehabilitation and employment situation.",[56,77,78,79,80,57],"Addiction, Substance","Safety Issues","Road Injury","Patient Compliance",{"date":36,"type":37},{"date":83,"type":37},"2018-02-02",{"date":41,"type":22},{"name":43,"class":44},{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":93,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":95,"conditions":96,"keywords":99,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":101,"startDateStruct":102,"completionDateStruct":103,"leadSponsor":104,"locationsCount":45},"100515000","ketamine-enhances-analgesia-and-mood-in-chronic-pain-patients-100515000","NCT05985811","Ketamine Enhances Analgesia and Mood in Chronic Pain Patients","Ketamine Analgesia Enhances Functional Quality and Mood in Chronic Pain Patients","Inclusion Criteria:\n\n* adult chronic pain patients\n* associated mood disorder\n* good treatment compliance\n* associated chronic insomnia\n* regular ketamine pain therapy injection\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* severe cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* cannabis use\n* stimulant use\n* substance abuse\n* poor treatment compliance\n* lack of ketamine pain therapy injection",{"count":94,"type":22},500,"Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.",[97,98],"Mood Disorder; Opioid","Mood Insomnia",[100],"Mood therapy",{"date":36,"type":37},{"date":83,"type":37},{"date":41,"type":22},{"name":43,"class":44},{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":4,"eligibilityCriteria":111,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":112,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":118,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":122,"locationsCount":45},"100511335","pain-clinic-staff-harassed-by-patients-prepost-covid-100511335","NCT05938101","Pain Clinic Staff Harassed by Patients Pre\u002FPost COVID","Pain Clinic Staff Harassment Caused by Patients Pre\u002FPost COVID Pandemic","Inclusion Criteria:\n\n* adult chronic pain patients\n\nExclusion Criteria:\n\n* pediatric chronic pain patients",{"count":21,"type":22},"Chronic pain may cause psychological or behavioral problems. Chronic pain patients occasionally harass the pain care providers. The COVID-19 pandemic caused major stress for the general population.\n\nQuantitative and qualitative analysis of prospective electronic and clinic diary data. Evaluation of incidents of clinic staff harassment; caused by patients, before and during COVID pandemic. Analysis of causative factors, incident outcome and lessons learned.",[115],"Patient Violence",[117],"Harassment by patient",{"date":36,"type":37},{"date":120,"type":37},"2020-01-02",{"date":41,"type":22},{"name":43,"class":44},{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":4,"eligibilityCriteria":129,"healthyVolunteers":16,"sex":17,"minAge":130,"maxAge":131,"enrollmentInfo":132,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":134,"conditions":135,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":137,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":141,"locationsCount":45},"100508293","covid-infection-in-pediatric-surgical-patient-100508293","NCT05898529","COVID Infection in Pediatric Surgical Patient","Prevalence of Asymptomatic COVID-19 Infection in Pediatric Surgical Patients","Inclusion Criteria:\n\n* surgical patients aged 2-17 years\n* informed consent for surgery\n* no COVID-19 diagnosis in previous 6 months\n* no history of nasal bleeding\n* no history of coagulopathy.\n\nExclusion Criteria:\n\n* patient refusal of testing\n* difficulty in obtaining consent\n* COVID-19 diagnosis in recent 6 month\n* history of nasal bleeding\n* history of coagulopathy.","2 Years","17 Years",{"count":133,"type":22},350,"Children infected with COVID-19 are mostly asymptomatic. There is a dearth of data on the epidemiology of COVID-19 in the pediatric population. This is a prospective observational clinical study of pediatric surgical patients. COVID-19 rapid antigen testing will be performed on pediatric patients.",[136],"COVID-19",{"date":36,"type":37},{"date":139,"type":37},"2023-07-01",{"date":41,"type":22},{"name":43,"class":44},{"id":143,"slug":144,"hasResults":11,"nctId":145,"briefTitle":146,"officialTitle":147,"acronym":4,"eligibilityCriteria":148,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":149,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":151,"conditions":152,"keywords":154,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":157,"startDateStruct":158,"completionDateStruct":160,"leadSponsor":161,"locationsCount":45},"100505520","magnesium-injection-ensures-steroid-avoidance-during-vaccine-viremia-or-immunocompromise-100505520","NCT05862454","Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise","Magnesium Injection Ensures Analgesia and Steroid Avoidance During Vaccination, Viremia or Immunocompromise","Inclusion Criteria:\n\n* adult chronic pain patients\n* previous interventional injection therapy\n* consent for interventional injection therapy\n* good treatment compliance\n* regular sleep diary\n* regular pain diary\n* informed consent for diary review\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* organ insufficiency\n* cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* unreliable diary\n* poor treatment compliance\n* previous adverse\u002Fallergic reactions to magnesium",{"count":150,"type":22},150,"Steroid injections are used for interventional pain management. However, their side-effect of immunosuppression may increase the risk of infections. Magnesium is an alternative anti-nociceptive injection that may be used instead of steroids.\n\nProspective observational study of patients who received magnesium injection for interventional pain therapy, instead of steroid injection. Post-injection data collection includes numerical rating pain score, and sleep quality score. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.",[153],"Steroid Metabolism Disorder",[155,156],"Magnesium","Steroid avoidance",{"date":36,"type":37},{"date":159,"type":37},"2020-07-02",{"date":41,"type":22},{"name":43,"class":44},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":4,"eligibilityCriteria":168,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":169,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":171,"conditions":172,"keywords":174,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":176,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":180,"locationsCount":45},"100506571","premedication-for-claustrophobic-patients-for-mri-scan-100506571","NCT05876117","Premedication for Claustrophobic Patients for MRI Scan","Clonidine and Lorazepam Premedication for Claustrophobic Patients During MRI Scan","Inclusion Criteria:\n\n* diagnosed with claustrophobia\n* previous incomplete MRI because of claustrophobia\n* adult patients\n* good treatment compliance\n* reliable Claustrophobia Questionnaire (CLQ) diary\n* reliable General Anxiety Disorder Questionnaire (GAD) diary\n* informed consent for diary review\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* poor treatment compliance\n* cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* unreliable diary\n* cannabis use\n* excessive alcohol intake\n* previous adverse\u002Fallergic reactions to clonidine\n* previous adverse\u002Fallergic reactions to lorazepam",{"count":170,"type":22},50,"Claustrophobia is an irrational fear of restriction and suffocation. It is a specific phobia, according to DSM 5. Claustrophobic patients may fear that restriction of their limbs will hinder their ability to move quickly towards safety. MRI may trigger claustrophobia, because this diagnostic procedure involves a patient laying in a narrow tube. Premedication before MRI scan may occasionally reduce claustrophobia.\n\nProspective observational crossover study of claustrophobic patients who are undergoing MRI scan. At alternate MRI scan sessions, each patient receives rotational premedication using Lorazepam 1mg; or Clonidine tablet 0.2mg; or combined Clonidine 0.2mg + Lorazepam 1mg.\n\nPatient will use Claustrophobia Questionnaire, a validated tool, to collect data on the days before and after each MRI scan. CLQ is a patient-administered tool used to assess claustrophobia. In addition, patient will use General Anxiety Disorder Questionnaire, a validated tool, to collect data on the days before and after each MRI scan. GAD-7 is a patient-administered tool that is used to assess anxiety.",[173],"Claustrophobia",[175],"Claustrophobia MRI",{"date":36,"type":37},{"date":178,"type":37},"2020-07-04",{"date":41,"type":22},{"name":43,"class":44},{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":186,"acronym":4,"eligibilityCriteria":187,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":188,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":190,"conditions":191,"keywords":194,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":196,"startDateStruct":197,"completionDateStruct":199,"leadSponsor":200,"locationsCount":45},"100512007","caudal-analgesia--anticoagulated-patient-100512007","NCT05946850","Caudal Analgesia & Anticoagulated Patient","Caudal Analgesia in Anticoagulated Chronic Pain Patients","Inclusion Criteria:\n\n* adult chronic pain patients who undergo caudal analgesia\n\nExclusion Criteria:\n\n* chronic pain patients who refuse caudal analgesia",{"count":189,"type":22},100,"Caudal analgesia is an effective intervention for lumbosacral pain. Some chronic pain patients take anticoagulants for vasculopathy treatment. Anticoagulation limits the use of caudal analgesia because of the risk of epidural bleeding. Caudal analgesia may be safe and effective in anticoagulated chronic pain patients.\n\nQuantitative analysis of prospective clinical data. Evaluation of caudal analgesia efficacy and safety in anticoagulated chronic pain patients. Analysis of outcome, and complications.",[192,193],"Lumbar Pain Syndrome","Anticoagulants and Bleeding Disorders",[195],"Caudal analgesia",{"date":36,"type":37},{"date":198,"type":37},"2008-01-02",{"date":41,"type":22},{"name":43,"class":44},{"id":202,"slug":203,"hasResults":11,"nctId":204,"briefTitle":205,"officialTitle":206,"acronym":4,"eligibilityCriteria":111,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":207,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":208,"conditions":209,"keywords":212,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":214,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":218,"locationsCount":45},"100511920","discrimination-harassment-of-pain-staff-caused-by-patient-100511920","NCT05945719","Discrimination Harassment of Pain Staff Caused by Patient","Discrimination and Harassment of Pain Clinic Staff Caused by Patients",{"count":21,"type":22},"Chronic pain is associated with mental disorders, and some patients have behavioral issues. Some patients may sexually or racially harass pain clinic staff. Healthcare staff do not usually report sexual or racial harassment perpetrated by patients.\n\nQuantitative and qualitative analysis of prospective electronic and clinic diary data. Evaluation of incidents of sexual and racial harassment of clinic staff; perpetrated by patients. Analysis of causative factors, incident outcome, system factors and lessons learned.",[210,211],"Abuse, Sexual","Abuse, Workplace",[213],"Harassment by patients",{"date":36,"type":37},{"date":216,"type":37},"2017-11-01",{"date":41,"type":22},{"name":43,"class":44},{"id":220,"slug":221,"hasResults":11,"nctId":222,"briefTitle":223,"officialTitle":223,"acronym":4,"eligibilityCriteria":224,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":225,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":226,"conditions":227,"keywords":229,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":231,"startDateStruct":232,"completionDateStruct":234,"leadSponsor":235,"locationsCount":45},"100507128","kratom-use-disorder-management-using-clonidine-andor-buprenorphine-100507128","NCT05883358","Kratom Use Disorder Management Using Clonidine and\u002For Buprenorphine","Inclusion Criteria:\n\n* adult patients\n* Kratom dependence\n* Kratom withdrawal syndrome\n* Kratom withdrawal therapy\n* good treatment compliance\n* reliable Subjective Opiate Withdrawal Scale (SOWS) diary\n* reliable Clinical Opiate Withdrawal Scale (COWS) diary\n* informed consent for diary review\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* poor treatment compliance\n* cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* unreliable diary\n* cannabis use\n* excessive alcohol intake\n* previous adverse\u002Fallergic reactions to clonidine\n* previous adverse\u002Fallergic reactions to buprenorphine",{"count":170,"type":22},"Kratom is used for stimulant, analgesic, anxiolytic, and sedative effects. There is inadequate knowledge about Kratom addiction. Kratom withdrawal may be treated like opioid withdrawal.\n\nProspective observational crossover study of consenting adults who are undergoing Kratom withdrawal management. On alternate weeks, each patient receives treatment using Buprenorphine 5cmg\u002Fhr patch; or Clonidine tablet 0.1mg 4hourly; or combined Clonidine tablet 0.1mg 4hourly + Buprenorphine 5cmg\u002Fhr patch. Each patient will undergo treatment for 12 weeks.\n\nPatients will use Subjective Opiate Withdrawal Scale (SOWS) to collect data on daily basis. SOWS is a patient-administered tool that is used to record the severity and presence of opiate withdrawal. The physician will also use Clinical Opiate Withdrawal Scale (COWS) to collect data on weekly basis. COWS is a clinician-administered tool that is used to record the signs of opiate withdrawal. A change in the COWS and SOWS scores by 6-points is considered significant.",[228],"Withdrawal Syndrome",[230],"Kratom",{"date":36,"type":37},{"date":233,"type":37},"2018-07-02",{"date":41,"type":22},{"name":43,"class":44},{"id":237,"slug":238,"hasResults":11,"nctId":239,"briefTitle":240,"officialTitle":240,"acronym":4,"eligibilityCriteria":241,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":242,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":243,"conditions":244,"keywords":246,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":249,"startDateStruct":250,"completionDateStruct":252,"leadSponsor":254,"locationsCount":45},"100486740","lemborexant-vs-zopiclone-vs-clonidine-for-insomnia-treatment-in-chronic-pain-patients-100486740","NCT05618002","Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients","Inclusion Criteria:\n\n* adult chronic pain patients\n* good treatment compliance\n* severe chronic insomnia\n* failure of non-pharmacologic sleep therapy\n* regular zopiclone therapy for 3 months or more\n* regular sleep diary\n* regular pain diary\n* informed consent for diary review\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* obstructive sleep apnoea\n* body mass index (BMI) ≥40\n* organ insufficiency\n* cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* unreliable diary\n* cannabis use\n* regular alcohol intake\n* stimulant use\n* substance abuse\n* poor treatment compliance\n* high dose opioid\n* gabapentinoid use\n* sedative use\n* mild insomina\n* irregular zopiclone intake\n* regular zopiclone therapy for less than 3 months\n* previous adverse\u002Fallergic reactions to clonidine or zopiclone",{"count":150,"type":22},"Prospective observational crossover study of 150 consenting adult patients who are undergoing chronic pain management. For insomnia treatment, each patient ingests prescribed doses of Lemborexant or Zopiclone or Clonidine on alternate nights. Each patient uses a special validated sleep diary to collect data including pain score, sleep score, sleep duration, sleep medication type, and adverse effects. Each patient completes the diary for 3 continuous weeks. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.",[245,57],"Chronic Insomnia",[247,248],"Sedative","Hypnotic",{"date":36,"type":37},{"date":251,"type":37},"2022-11-08",{"date":253,"type":22},"2025-12-11",{"name":43,"class":44},""]